2011 ILSI Annual Report - International Life Sciences Institute

International Life 

Sciences Institute 

2011 ILSI 

Annual Report

2 Letters from the President and Chair 

4 Global Issue: Water 

6 Global Issue: Risk Assessment 

8 Global Issue: Biotechnology 

10 Global Issue: Functional Foods 

12 Global Issue: Obesity 

15 2011 ILSI Board of Trustees 

16 2011 ILSI Members 

20 2011 Revenue and Expenses

ILSI believes scientists from industry, 

academia, and government can and should 

work together in an open, transparent manner. 

The collaborative nature of our work – which 

is part of the larger body of scientific evidence – 

helps industries make safe, healthy products and 

helps governments provide effective and practical 

guidance to ensure public health and well-being 

and environmental safety. 

Fresh. Energetic. Bold. 

ILSI adopted a new logo in 2011 – 

one designed to catch the eye 

and convey the dynamism of 

the organization. It reflects the 

enthusiasm we have for our mission 

to deliver science that leads to a 

healthier world. 

While logo interpretation is often 

subjective, the abstract nature of 

the symbol has underlying meaning. 

The concentric circles simultaneously 

portray a stylized plasmid map 

signifying our focus on the life 

sciences and a world globe 

representing our international reach. 

The way in which the individual lines 

work together to create a whole 

expresses our commitment to 

collaboration and is an emblem of 

the synergy of our work among 

ILSI entities and with our partners. 

The fresh, bold, and energetic logo is 

an effective tool to catch attention and 

build recognition of our contribution 

to the science that helps makes the 

world a better place. Its implementation 

online and in print is part of an 

ongoing communications strategy 

to raise awareness of ILSI’s value within 

the scientific community.

From the President 

Peter van Bladeren, PhD 

President 

International Life Sciences Institute 

The central challenge laid out in the ILSI strategic plan 

is to “enhance ILSI’s scientific contribution to improve 

human health and the environment.” ILSI strives to achieve 

this goal by continually examining how well our scientific 

portfolio is meeting important health and environmental 

concerns. Our Global Issues – common topics of interest 

across ILSI entities and featured in this annual report – are 

how we prioritize the science to meet this central challenge. 

In 2011, we added Water to our existing issues: Risk 

Assessment; Biotechnology; Functional Foods; and Obesity. This is 

a response to the global threat of diminishing sources of safe water, 

and our programs are being designed to help achieve cost-effective 

sustainability for drinking water and food production. 

Another goal outlined in our strategic plan is to become a preferred 

resource for science; that is, to be recognized for delivering quality, 

useful science. While the Five Global Issues structure allows us to 

manage our dynamic scientific portfolio, proactive communications 

is making people aware of our role in today’s important issues and in 

getting the science into the hands of the people who make decisions 

affecting the health and well-being of all of us. 

As part of this invigorated communications effort, ILSI has adopted 

a bold new logo – one that catches and keeps attention. Also, many 

branches are taking the initiative to reach out to new audiences 

in creative ways. ILSI Europe and ILSI Brasil are examples where 

the media is being engaged to effectively raise awareness of ILSI’s 

scientific products. The quantitative results are illustrative; in the 

past two years our website has gone from having about 1,000 visits 

per month to an average of 9,000 hits per month. Every week we 

receive requests to join our newsletter distribution list from our core 

audiences: scientists in academia; government; and industry. 

Our objective for 2012 is to accelerate this communications 

momentum. The bright logo, an assertive and coordinated communications 

effort across ILSI entities, and a foundation of excellent 

science will further position ILSI as a go-to scientific organization. 

2

From the Chair 

I 

LSI’s global network is one of our greatest assets. 

Our branches, international committees, and the 

Research Foundation work at the national, regional, 

and international level allowing ILSI to nurture 

partnerships and foster collaboration at the very local 

level and the global level simultaneously and seamlessly. 

You can see this in the joint programs we develop 

between entities and with the external partners we have 

“on the ground,” as they say. 

Sushila Chang, PhD 

Chair 

ILSI Board of Trustees 

International collaboration – true collaboration where more than 

one partner shares in the process for designing, implementing, 

and funding programs – is hard work. It requires patience, 

dedication, and sometimes finesse to establish a partnership and 

maintain it. This is why another of our greatest assets is our staff. 

It takes the perseverance and creativity of committed individuals 

to recognize opportunities, to mobilize resources, and assist our 

volunteer leadership in taking full advantage of prospects for 

forging new partnerships and expanding existing relationships, 

and all this across time zones. Therefore, in 2011, the ILSI Board of 

Trustees made a commitment to help staff help each other grow. 

We instituted a grants process by which we can support an exchange 

program. Staff from one branch will spend time at another branch 

sharing ideas and learning new ways of approaching their work. The 

exchange is designed so both the visiting branch and the hosting 

branch benefit from a cross-fertilization of ideas, whether it be on 

basic project management, on communications, or on fostering 

meaningful collaboration. In addition to the hands-on learning it 

provides, the exchange creates lasting relationships in themselves. 

It brings branches closer together and makes cooperation more 

second nature. 

Several members have already given generously to fund the exchange 

and we hope more will do the same. The program meets a tenet of 

the ILSI strategic plan to build staff capacity at all levels. It also invests 

in people – for the sake of the organization but also for the sake of the 

individual his or herself. It is a way to strengthen the skills of the very 

people who make ILSI strong. 

I look forward to the success stories stemming from this exciting 

exchange program. 

3

Water Sustainability for 

Drinking and Food Production 

The ILSI Board of Trustees 

identifies health and 

scientific topics of common 

concern or interest. These 

are issues affecting millions of 

people in all parts of the world. 

The Board refers to these as 

“Global Issues” – broadly 

defined categories used to 

track how ILSI’s work is improving 

our scientific understanding of today’s 

important concerns. 

Previously, the ILSI Board defined 

four Global Issues: Risk Assessment; 

Biotechnology; Functional Foods; and 

Obesity. In 2011, the Board added a 

new issue: Water. 

Although ILSI’s work on water issues is 

not new, the Board of Trustees elevated 

the topic as access to clean water has 

become as a more critical, global health 

problem in recent years. National 

governments and international health 

agencies are increasingly worried about 

shortages of water and inadequate 

water sanitation in urban and rural 

settings. More recently, the food and 

beverage industries are concerned 

about barriers to sustaining safe water 

supplies, which is due in part to a lack 

of best practices in the application of 

current technology; out-dated science 

policy on risks; confounding national 

and political pressures for water use; 

and even perceptions of what kind 

of water can be used in what ways. 

ILSI programs, both existing and new, 

are designed to bring together health 

and technical experts from a range of 

disciplines to work to fully understand 

the situation on local, regional, and 

international scales so appropriate 

solutions can be implemented. 

ILSI Europe Leads a Global 

Initiative on Water 

ILSI Europe established a new 

program on water known as 

“Water and Sanitation Perspectives.” 

While the program is comprehensive, 

an initial focus has been set on the 

quality of water used in the production 

of fresh produce. In March 2011, 

ILSI Europe convened a meeting to 

define the scope of activities and the 

shared responsibilities among the 

initiative’s participants and supporters. 

The meeting resulted in a specific 

outline for an overview publication, 

which is in development and 

expected to be published in 2012. 

The publication looks at fresh produce 

and microbial safety concerns; the 

quality of irrigation waters used in fresh 

produce production; microbial hazards 

linked to irrigation and process waters; 

and microbial risk assessment. The 

publication will provide a scientific gap 

analysis and make recommendations 

for next steps. 

ILSI Europe is building a broad 

coalition of program partners. Eight 

ILSI branches (India, Japan, Korea, 

México, North Andean, South Andean, 

South Africa, and Southeast Asia 

Region) are collaborating with 

ILSI Europe. The World Health 

Organization and the Food and 

Agriculture Organization of the 

United Nations are providing technical 

support. Representatives from these 

groups and additional ones, such as 

the International Water Association and 

the International Water Management 

Institute, serve on an Advisory Group 

to the initiative. 

4

Innovation in Water Reuse in 

the Bottling Industry 

In 2011, the ILSI Research Foundation’s 

Center for Risk Science Innovation and 

Application launched a water program 

designed to apply new and sometimes 

innovative engineering, monitoring, 

and risk management approaches to 

the reduction of water use in the food 

and beverage industry. An initial project 

focuses on establishing guidelines for 

water reuse in the bottling industry. 

The guidelines, developed by a panel 

of experts, will lead to reductions in 

the bottling industry’s water footprint 

(total liters of water required to produce 

a liter of product) by guiding the 

application of monitoring and safety 

evaluation protocols for purification 

processes and technologies that 

have so far only been used in pilot or 

experimental applications. 

5

Changing the Philosophy 

Behind Risk Assessment 

Throughout 2011, the ILSI 

Health and Environmental 

Sciences Institute (HESI) built 

momentum on its initiative to 

improve how risk assessment 

is conducted: Risk Assessment 

for the 21st Century (RISK21). 

This effort, with the potential 

for far-reaching impact, seeks 

to improve human and environmental 

health by fundamentally shifting the 

focus of risk assessment to thinking 

about the problem that needs to be 

addressed first, followed by leveraging 

existing information; conducting 

additional toxicology testing and 

gathering more exposure information 

when needed; and incorporating new 

methods into the risk assessment process. 

This shift places emphasis on problem 

formulation – i.e., thinking about the 

problem that needs to be addressed first. 

Problem formulation defines the scope 

of an exposure and effect of concern 

and the objectives for addressing them, 

and generates and evaluates preliminary 

hypotheses to address the concern. 

Problem formulation first uses existing 

information to help inform the risk 

assessment and applies new methods to 

the risk assessment whenever available 

and appropriate. RISK21 views problem 

formulation as an iterative process 

that identifies data gaps and leads to 

full understanding of a necessary level 

of certainty. 

Problem formulation is key to RISK21’s 

mission to bring applicable, accurate, 

and resource appropriate approaches to 

an evolving world of human health risk 

assessment. 

In 2011, HESI held a workshop and 

presented at the International Society of 

Exposure Science to educate audiences 

about RISK21 and to get feedback from 

diverse stakeholders on the project’s 

goals and how to achieve them. With 

over 50 participating organizations from 

academia, government, and industry, 

RISK21 epitomizes HESI’s commitment 

to the tripartite approach to generating 

scientific knowledge. 

In 2012, HESI will work with its 

partners on case studies designed 

to validate the effectiveness of the 

paradigm shift RISK21 represents. 

6

Risk Management Harmonization 

In today’s globalized world, the 

movement of agricultural products 

and food across national borders 

creates a shared responsibility for 

public health and safety. Whether 

potential contamination is intentional 

or unintended, governments, industries, 

and important world bodies such 

as the World Health Organization 

must cooperate on setting standards 

and risk assessment methods for 

harmonized approaches. ILSI 

Southeast Asia Region has been a 

leader in promoting the importance of 

harmonization throughout Southeast 

Asia and Australasia and in facilitating 

the exchange of perspectives among 

national, regional, and international 

stakeholders. ILSI Southeast Asia 

Region’s 2011 seminar “Food 

Contaminants: Emerging Issues 

and Risk Management Strategies” 

brought together industry and 

government decision-makers to 

discuss common concerns about 

the prevention and management 

of chemical and microbial food 

contamination. In conjunction with 

this event, ILSI Southeast Asia 

facilitated the “9th ASEAN Food 

Safety Standards Harmonization 

Workshop,” where industry, academic, 

and ASEAN country representatives 

discussed how to fill scientific gaps impeding 

the progress of harmonization. 

A Risk from Risk Perception? 

The Research Foundation’s Center for 

Risk Science Innovation and Application 

(RSIA) examined the unintended 

consequences of the perception of risk 

(versus actual risk) on decision making. 

Recognizing human perception of risk 

can lead to behavior that reduces health 

risk (avoids a risk); increases health risk 

(replaces an avoided risk with something 

riskier); or does not affect health risk 

but has adverse economic effects, 

RSIA convened a 2011 workshop on risk 

perception. RSIA gathered risk assessment, 

risk policy, and economics experts 

from academia, government, industry, 

and nongovernmental organizations to 

explore public health risks stemming 

from errant perceptions of risk. 

The workshop spurred interest in 

case studies, to be initiated in 2012, 

which will further help identify, assess, 

and address public health risk from 

perceptions of risk. 

RISK21’s efforts will lead to the ability to assess more 

exposure situations, toxicity scenarios, and chemicals 

with existing resources; use far fewer animals in animal 

testing; and reduce the number of false positive 

and false negatives while simultaneously increasing 

confidence in the risk assessment. 

7

International Colloboration 

on Biotechnology 

The ILSI Research 

Foundation’s Center for 

Environmental Risk Assessment 

(CERA) is providing technical 

support to the Government of 

India as it works to establish 

an appropriate framework for 

conducting environmental risk 

assessment (ERA) of genetically 

engineered (GE) plants in India. The 

approach has been to assess the vast 

international experience in ERA, focusing 

on the scientific aspects of ERA versus 

policy or political considerations, so 

India can develop country-appropriate 

ERA guidance based on established 

principles and tested methods. 

ILSI’s biotechnology programs address scientific 

issues related to the safe development and 

distribution of products derived from modern 

agricultural biotechnologies. 

Success through Collaboration 

Biotechnology is an area where ILSI 

is especially successful in collaborating 

across entities. Led by the ILSI 

International Food Biotechnology 

Committee’s (IFBiC) commitment to 

scientific outreach and capacity 

building, and the ILSI Research 

Foundation’s focus on creating 

sustainable partnerships, ILSI and its 

branches have been able to connect 

local thought leaders and international 

experts throughout 2011. IFBiC worked 

with ILSI Southeast Asia Region, 

ILSI Korea, and ILSI India to examine 

the latest developments in sampling 

and detection methods. It also 

presented at a workshop organized 

by the ILSI Health and Environmental 

Sciences Institute and ILSI Focal Point 

in China on the use of mammalian 

toxicology studies in the safety assessment 

of whole foods from genetically 

engineered crops. The ILSI Research 

Foundation, through the Foundation’s 

Center for Environmental Risk 

Assessment (CERA), co-organized 

workshops with ILSI Mexico, ILSI North 

Andean, ILSI South Andean, ILSI Korea 

and ILSI Japan; events that brought 

together regulators, academic experts, 

and industry scientists to discuss 

improving systematic approaches to 

the environmental risk assessment 

(ERA) of genetically engineered 

plants. CERA is also working with 

ILSI Argentina on a multi-year research 

project exploring the issue of data 

transportability in ERA. 

8

In 2011, this collaboration included 

the seminal “South Asia Conference on 

Current Approaches to Environmental 

Risk Assessment of Genetically 

Engineered Crops.” This important 

three-day event, which included 

symposia and a technical workshop, 

was organized by CERA and Biotech 

Consortium India Limited with 

support from the Indian government’s 

Department of Biotechnology and 

Ministry of Environment and Forests, 

and the United States Agency for 

International Development. 

The conference succeeded in its goal to 

bring together scientists and professionals 

from India and abroad to discuss in detail 

the science and the practice of ERA. 

Case studies of experience with ERA 

in Australia, India, The Philippines, 

and other countries set the stage for the 

discussions and established basic points 

of agreement. This included recognition 

that the science of ERA remains largely 

the same from country to country and 

that ERA harmonization across national 

borders can be achieved. 

Technical sessions then addressed the 

importance of problem formulation 

as the essential first step in ERA; field 

trial data collection and interpretation; 

understanding gene flow; post release 

environmental surveillance; and insect 

resistance management. Panel sessions 

were used to review horizontal gene 

transfer; the use of antibiotic resistance 

genes as selectable markers in GE plant 

development; and management of 

herbicide tolerance. 

The case studies, technical sessions, and 

panel discussions exposed participants 

from Indian Central and State governments; 

state agricultural universities; 

research institutes; and industry to a 

wealth of knowledge and experience 

on ERA. Throughout the conference, 

participants were encouraged to make 

observations and provide suggestions 

based on the information shared. The 

collective “way forward” determined by 

presenters and participants included a 

recommendation to develop guidance 

that will facilitate the establishment of 

data requirements and methods for data 

collection, that leads to a transparent 

and predictable ERA process and public 

confidence in the ability of ERA to 

address environmental safety. 

ILSI Recognized as a 

Scientific Resource 

The Organization for Economic 

Cooperation and Development (OECD) 

has been involved in biotechnology 

for over 30 years, with current interest 

in the safety of novel foods and feed; 

harmonization of regulatory oversight 

of biotechnology across national 

borders; the role biotech can play in 

adaption to climate change; and the 

ability of biotech to support their 

“Green Growth Strategy” whereby 

countries meet development goals 

while safeguarding their natural assets. 

Recognizing ILSI’s scientific expertise 

in biotechnology, OECD invited ILSI 

to conduct an educational workshop 

on a range of relevant topics. Held in 

2011 in France, the workshop was 

organized by the ILSI International 

Food Biotechnology Committee 

(IFBiC) in collaboration with the 

ILSI Health and Environmental 

Sciences Institute. Industry and 

academic experts delivered technical 

information on quantifying and 

comparing safety assessments for 

allergens; safety assessment of 

stacked events; and the use of 

mammalian toxicology studies for 

the safety evaluation of genetically 

derived crops. IFBiC also showcased 

its Crop Composition Database 

(www.cropcomposition.org). 

OECD delegates were impressed 

with the scientific scope and technical 

focus of the workshop and have 

suggested similar workshops be 

organized in the future. 

9

Functional Foods – 

Beyond Basic Nutrition 

ILSI has been at the front of the 

science supporting functional 

foods – foods and food components 

that provide health benefits 

beyond basic nutrition – since 

its pivotal 1995 conference 

“Functional Foods: East–West 

Perspectives.” At that event, 

experts from Asia, Europe, and 

the Americas debated basic concepts 

related to definition, measuring efficacy, 

and claim substantiation. ILSI Europe 

organized additional international 

conferences in 2001, 2007, and, most 

recently, 2011. The programs of these 

meetings reflect how sophisticated the 

science has become over the years and 

how some of the questions still to be 

answered have become more exciting 

because of their potential to improve 

health and well-being. 

As its title implies, the 2011 conference 

“Health Benefits of Foods – from 

Emerging Science to Innovative 

Products” focused on the possibilities of 

functional foods. Not only did experts 

present on fundamental principles such 

as food characterization (i.e., evaluation 

of food components), they also speculated 

on the role functional foods can play in 

preventative health and thereby relieve 

pressure on global health care costs. 

The conference was also an inauguration 

of ILSI Europe’s new program “Marker 

Initiative in Nutrition Research.” 

Clinical endpoints and biological 

markers are critical to objectively 

measuring purported health effects of a 

specific food or food component. The 

comparison of existing and new data, 

however, is hampered in part by a lack 

of consistency in marker selection. 

Through its Marker Initiative, ILSI 

Europe is facilitating the development 

and acceptance of criteria for using 

markers in different fields of nutrition. 

Functional Foods in South Asia 

and South America 

ILSI-India held a conference in early 

2011 entitled “Processed Food and 

Beverages for Health: Beyond Basic 

Nutrition” whose program highlighted 

the east–west perspectives on functional 

foods. Leading authorities on functional 

foods and health claims came from 

Europe, India, Japan, and Singapore to 

review general principles and specific 

food components and also to compare 

what science is required in different 

regulatory systems and/or guidelines 

around the world. Later in the year, 

ILSI-India organized the conference 

“Health and Longevity through Chai” 

which looked specifically at tea 

consumption and health and the 

potential to enhance tea with herbs 

and micronutrients. 

ILSI North Andean and ILSI South 

Andean also fostered an exchange of 

ideas on functional foods in 2011. 

ILSI North Andean’s program featured 

a keynote speaker from ILSI Europe 

and focused on what was learned from 

both successful and unsuccessful 

attempts to substantiate health claims. 

Through the case studies presented 

at the meeting, ILSI North Andean 

demonstrated how existing knowledge 

can be used in the regional context of 

Colombia, Ecuador, and Venezuela. 

ILSI South Andean’s symposium 

examined the health benefits of 

specific components (e.g., vitamin D 

and Omega-3 fatty acids) and explored 

cutting-edge developments in the field 

of nutraceuticals – foods and food 

components used to treat illness. 

10

Communicating the Science 

ILSI Europe took a bold, creative step 

with its conference “Health Benefits of 

Foods” by inviting members of the 

press to attend and report on the 

science. While ILSI has begun engaging 

science journalists, notably in ILSI 

Korea and ILSI Brasil, ILSI Europe’s 

efforts were especially comprehensive. 

They facilitated interviews between 

speakers and reporters, including for 

TV broadcast, and sent daily news 

releases to science writers throughout 

Europe. The goal is two-fold: increase 

awareness of the science and of ILSI’s 

role in contributing to that science. 

The success of their proactive efforts 

is reflected by the number of visits 

ILSI Europe’s website receives. 

ILSI’s work on functional foods is instrumental 

in establishing the science needed to substantiate 

health claims for foods and food components that 

go beyond basic nutrition. 

Similarly, ILSI Argentina has been active 

in reaching out to new audiences. In 

2011, it partnered with the Argentine 

Foundation of Nutrition and ArgenBio 

to create the Council for Food Safety 

and Nutrition Information (CISAN). 

Using web-delivered information via 

news articles, fact sheets, videos, and 

other tools, CISAN is extending the 

reach of science to health professionals, 

science communicators, and the 

general public. 

11

ILSI is Recognized 

for its Obesity Work 

Obesity is a global 

epidemic affecting 

developed and 

developing countries 

alike, and its causes 

and consequences 

are complex and 

far-reaching. Over 

the years ILSI has 

contributed to the science of mechanisms 

associated with energy balance; 

improved our understanding of obesity’s 

comorbidities; examined how food and 

food components can play a role in 

maintenance of ideal weight, prevent 

weight gain, or promote weigh loss; and 

developed school- and community 

based intervention programs that 

promote healthy lifestyles. However, 

obesity remains an international health 

challenge and ILSI remains committed 

to this important and complicated 

public health threat. 

The Health Ministry of China has 

commissioned ILSI Focal Point in 

China to develop “The Method to 

Determine Overweight and Obesity in 

Chinese Adults.” The document, which 

will include categories determined 

by body mass index, will help health 

practitioners identify at-risk individuals. 

The Ministry’s recognition of ILSI Focal 

Point in China for this important task 

is a result of the Focal Point’s successful 

work on the first ever Physical Activity 

Guidelines for Chinese Adults. Drafted 

by experts in physical activity and sport 

medicine and in context of Chinese 

society and culture, the guidelines were 

formally put into trial use in 2011 by 

the Ministry of Health. The Guidelines 

document is a tool for health and 

physical education professionals to 

develop individual and communitybased 

physical activity programs. It is 

also a reference for the science underlying 

the importance of adequate physical 

activity for achieving and maintaining 

healthy weight and overall health. 

Also in 2011, ILSI Focal Point in China 

began an intervention study to better 

understand motivation and compliance 

when it comes to weight-loss programs. 

In partnership with Weight Watchers 

International, preliminary results 

show a mean weight loss of 4kg in 

subjects. The final results of the study 

will be used to design and implement 

better public health strategies for 

individual and population-based 

weight management programs. 

Community-based Solutions 

in Australia 

In a second collaborative meeting 

with the Sydney (Australia) West 

Area Health Service and its Centre for 

Health Innovation and Partnership, 

ILSI Southeast Asia Region coorganized 

a 2011meeting to share best 

practices on how to encourage and 

enable healthy eating and active living. 

ILSI Southeast Asia Region and the 

Sydney West Area Health Service are 

especially interested in building 

successful community initiatives 

through innovative partnerships; food 

interventions; and promoting physical 

activity in households, workplaces, and 

schools. The meeting resulted in an 

updated evidence-based understanding 

of issues related to the promotion of 

sustainable community health. The 

two organizations plan to continue 

their collaboration to determine how 

to implement best practices in different 

community settings. 

Understanding Caloric and 

Non-Caloric “Sweetness” 

The 2010 Dietary Guidelines for 

Americans issued by the US Department 

of Agriculture (USDA) state that 

“replacing added sugars with non-caloric 

sweeteners may reduce calorie intake in 

the short-term…” but then go on to 

say “…yet questions remain about their 

effectiveness as a weight management 

strategy.” The statement reflects a 

questioning within the health professional 

community about the appropriate 

role for non- or low-calorie sweeteners 

as a weight management tool. The 

debate in part prompted ILSI North 

America to review the current science 

with the goal to identify and resolve 

outstanding concerns. 

As part of their efforts, ILSI North 

America convened a 2011 workshop on 

low-calorie sweeteners. The comprehensive 

program first examined the 

neuroscience of sweet taste and the 

role sweetness plays in food intake; 

then reviewed the obesity epidemic, 

focusing on the problem of childhood 

12

overweight now and into the future. 

Workshop participants discussed the 

limitations of observational studies and 

the use of animal toxicological studies 

of sweeteners in predicting effects on 

human weight management. Experts 

compared the effects of sugars and 

low-calorie sweeteners on satiety, 

glucose response, and insulin levels. 

ILSI North America will publish 

proceedings from the meeting in 2012. 

The individual papers will summarize 

what is currently known about low-calorie 

sweeteners and outline opportunities for 

additional research. In addition, ILSI 

North America sought to immediately 

extend the reach of what is already 

known about low-calorie sweeteners, 

especially to health educators. To do 

this, ILSI North America partnered 

with the USDA’s eXtension program 

to create and disseminate a webinar on 

low-calorie sweeteners. eXtension is 

an online resource for information on 

human and animal health. The webinar 

presented findings from the workshop 

to over 100 USDA extension agents 

across the United States. 

ILSI Research Foundation 

Partners with FlagHouse 

The ILSI Research Foundation chose 

FlagHouse, Inc. to be its exclusive 

distributor of TAKE 10! ® and launched 

a redesigned website (www.take10.net). 

TAKE 10! is a 5-K classroom-based 

intervention program combining gradespecific 

academic learning objectives 

with short periods of structured 

physical activity. Research shows 

children who participate in TAKE 10! 

have improved attention spans, test 

scores, and body mass indices. It is 

currently in over 55,000 classrooms in 

the United States and pilots are being 

tested internationally by ILSI Brasil, 

ILSI Europe, ILSI Focal Point in China, 

and ILSI North Andean. FlagHouse 

is a supplier of tools and resources 

intended for educators in physical 

activity, recreation, education, and 

special needs. Together, the Research 

Foundation and FlagHouse are 

promoting this research-developed 

and validated program as a tool to 

improve lifestyles. 

13

2011 ILSI Board of Trustees 

ILSI is governed by its Board of 

Trustees, the members of which come 

from academia, government, and 

industry. These dedicated volunteers 

establish organizational policy, guide 

scientific direction, and ensure scientific 

integrity and financial transparency. 

Dr. Peter van Bladeren 

ILSI President 

Nestlé Research Center 

Switzerland 

Dr. Sushila Chang 

Chair, ILSI Board of Trustees 

Singapore University of 

Technology and Design 

Singapore 

Dr. Todd Abraham 

Kraft Foods 

USA 

Dr. Marc Bonnefoi 

sanofi-aventis 

USA 

Dr. Alan Boobis 

Imperial College London 

United Kingdom 

Dr. Henry Chin 

Coca-Cola Company 

USA 

Dr. Samuel Cohen 

University of Nebraska Medical Center 

USA 

Dr. John Doull 

University of Kansas Medical School 

USA 

Dr. Marion Ehrich 

VA-MD Regional College 

of Veterinary Medicine 

USA 

Dr. Mark Empie 

Archer Daniels Midland 

USA 

Dr. Gerhard Eisenbrand 

University of Kaiserslautern 

Germany 

Mr. Reginald Fletcher 

Kellogg’s Europe 

Ireland 

Dr. Jay Goodman 

Michigan State University 

USA 

Dr. Phil Guzelian 

University of Colorado Health 

Science Center (Retired) 

USA 

Dr. Jerry Hjelle 

Monsanto Company 

USA 

Dr. Michael Knowles 

Coca-Cola Europe 

Belgium 

Dr. Milan Kovác (resigned July 2011) 

Ministry of Agriculture & Rural 

Development 

Slovakia 

Dr. Tamotsu Kuwata 

University of Human Arts and Sciences 

Japan 

Dr. Ik-Boo Kwon 

Lotte Company 

Korea 

Dr. Asahi Matsuyama 

Kikkoman Corporation 

Japan 

Dr. John Milner 

National Cancer Institute 

USA 

Mr. Felipe Rodríquez 

Pepsico 

México 

Dr. P. K. Seth 

Lucknow Biotechology Park 

India 

Mr. Geoff Smith 

Nutrition Strategies International 

Singapore 

Dr. Lewis Smith 

Medical Research Council 

United Kingdom 

Dr. Geoff Thompson 

Groupe Danone 

France 

Dr. Sara Valdés Martínez 

University of México 

México 

Dr. Connie Weaver 

Purdue University 

USA 

Dr. Elizabeth Westring 

General Mills 

USA 

Dr. Flávio A.D. Zambrone 

Planitox 

Brazil 

Dr. Barry L. Zoumas 

(deceased August 2011) 

The Pennsylvania State University 

USA 

15

2011 ILSI Members 

ILSI is proud of its member support 

for its goal to foster collaboration 

among leading scientists from 

academia, government, and industry 

to identify and resolve scientific 

issues of common concern. 

ILSI Argentina 

Bayer S.A. 

Chacra Experimental Agrícola 

Santa Rosa 

Coca-Cola de Argentina S.A. 

Danone Argentina S.A. 

Danone Baby Nutrition 

Dow AgroSciences Argentina S.A. 

Grupo Arrayanes 

Kraft Foods Argentina S.A. 

Kromberg Fine Chemical S.R.L. 

Merisant Argentina S.R.L. 

Monsanto Argentina S.A.I.C. 

PepsiCo de Argentina S.R.L. 

Publitec S.A. Editora 

Syngenta Agro S.A. 

Unilever de Argentina S.A. 

ILSI Brasil 

Abbott Laboratórios do Brasil Ltda. 

Ajinomoto Interamericana Indústria 

e Comércio Ltda. 

Arcor do Brasil Ltda. 

Arysta Lifescience do Brasil Ltda 

BASF S.A. 

Bayer S.A. 

Beneo-Orafti Latinoamerica Coord. 

Regional Ltda. 

Bunge Alimentos 

Coca-Cola Indústrias Ltda. 

Corn Products Brasil 

Danisco Brasil Ltda. 

Danone Ltda. 

Dow Agrosciences Industrial Ltda. 

DSM Produtos Nutricionais Brasil Ltda. 

Fortitech South America Industrial 

e Comercial Ltda. 

Futuragene Brasil Tecnologia Ltda. 

Herbalife International do Brasil Ltda. 

Iharabras S.A. Indústrias Químicas 

Kellogg Brasil Ltda. 

Kraft Foods Brasil Ltda. 

Masterfoods Brasil Alimentos Ltda. 

Mead Johnson Nutritional 

Milenia Agro Ciências S.A. 

Monsanto do Brasil Ltda. 

Nestlé Brasil Ltda. 

Nutrimental S/A Industria e Comercio 

de Alimentos 

Pfizer Consumer Home Health 

Red Bull do Brasil Ltda. 

Sadia S.A. 

Sanavita Indústria e Comércio de 

Alimentos Funcionais Ltda. 

Solae do Brasil Ind. e Com. de 

Alimentos Ltda. 

Support Produtos Nutricionais Ltda. 

Syngenta Proteçao de Cultivos Ltda. 

Yakult S.A. Indústria e Comércio 

ILSI Europe 

Abbott Nutrition 

Ajinomoto Europe 

Barilla G&R Fratelli 

BASF SE 

Bayer CropScience BioScience 

Beverage Partners Worldwide 

(Europe) AG 

Bionov 

Biosearch Life 

Bunge Europe 

Campbell Soup Company 

Cargill 

Chiquita Brands International 

Clasado 

Coca-Cola Europe 

Colloïdes Naturels International 

Cosucra Groupe Warcoing 

Danisco 

Danone 

Dow Europe 

DSM 

DuPont de Nemours 

Firmenich 

FrieslandCampina 

Givaudan Schweiz 

Group Roquette 

H.J. Heinz 

Institut Mérieux 

Kellogg Europe 

Kikkoman Foods Europe 

Kraft Foods Europe 

Lallemand SAS 

Lavazza S.p.A 

Mars 

Martek Biosciences Corporation 

McDonald’s Europe 

McNeil Nutritionals Europe 

Mead Johnson Nutrition 

Merck Consumer Healthcare 

Monsanto Europe 

National Starch Food Innovation 

Naturex 

Nestlé 

PepsiCo International 

Pfizer Consumer Healthcare 

Premier Foods 

Procter & Gamble 

Puratos Group 

Red Bull 

Schwabegroup 

Sensus 

Seven Seas 

Solae Europe 

Soremartec - Ferrero Group 

SQTS - Swiss Quality Testing Services 

Südzucker/BENEO Group 

Syngenta Crop Protection 

Tate & Lyle 

Tereos-Syral 

Tetra Pak Research 

The International Nutrition Company 

Ülker Bisküvi San. Ve Tic A. S. 

Unilever 

Wild Flavors 

Yakult Europe B.V. 

16

ILSI Focal Point in China 

Abbott Laboratories 

Ajinomoto Co., Inc. 

Almond Board of California 

Amway (China) Co., Ltd. 

BASF (China) Co., Ltd. 

Bunge Limited 

Cargill Investments (China) Ltd. 

Carrefour (China) Foundation for 

Food Safety 

Coca-Cola (Shanghai) Beverages Ltd. 

Danisco (China) Co., Ltd. 

DSM (China) Ltd. 

Fonterra Commercial Trading 

(Shanghai) Company 

Groupe Danone (China) 

Givaudan Flavours (Shanghai) Ltd 

Herbalife 

H.J. Heinz Company 

IFF (China) Ltd. 

Kellogg 

Kraft Foods (China) Company Limited 

Mars Foods (China) Co., LTD. 

McDonald’s (China) Co., Ltd. 

Mead Johnson Pediatric Nutrition 

Institute (China) 

Monsanto Far East Ltd. 

Meiji Dairies Corporation 

Nestlé (China) Ltd. 

Nutrexpa-Cola Cao Tianjin Food 

Co., Ltd. 

PepsiCo (China) Limited 

Red Bull 

Roquette 

Shanghai Wyeth Nutritional Co., Ltd 

Symrise (Shanghai) Ltd. 

Tingyi (Cayman Islands) Holding Corp. 

Unilever Bestfoods (China) Co., Ltd. 

Wei Chuan Foods Corporation 

Wrigley Confectionery (China) Limited 

Yum! Restaurants China 



Abbott Laboratories 

Actelion Pharmaceuticals Ltd 

Allergan 

Amgen, Inc. 

Astellas Pharma Inc. 

AstraZeneca AB 

BASF Corporation 

Battelle Memorial Institute 

Bayer AG/Bayer CropScience 

Biogen Idec MA Inc. 

Boehringer Ingelheim GmbH 

Bristol-Myers Squibb Company 

Charles River Laboratories 

The Coca-Cola Company 

Covance Laboratories, Inc. 

Daiichi-Sankyo Co., Ltd. 

Data Sciences International, Inc. 

Dow AgroSciences, LLC/The Dow 

Chemical Company 

Dow Corning Corporation 

E.I. du Pont de Nemours and Company 

Eli Lilly and Company 

Experimental Pathology 

Laboratories, Inc. 

ExxonMobil Biomedical Sciences Inc. 

GlaxoSmithKline 

Hoffmann-La Roche, Inc. 

Institut de Recherches Int. SERVIER 

Johnson & Johnson Pharmaceuticals 

L’Oreal Corporation 

LyondellBasell Industries 

Merck & Co., Inc. 

Mitsubishi Tanabe Pharma Corp. 


Novartis Pharmaceuticals Corporation 

Pfizer, Inc. 

Portola Pharmaceuticals Inc. 

The Procter & Gamble Company 

Purdue Pharma L.P. 

Sanofi 

S.C. Johnson & Son, Inc. 

Shell Chemicals, Ltd. 

Stellar Biotechnologies 

Sumitomo Chemical Co., Ltd. 

Syngenta Ltd. 

Takeda Pharmaceutical Company 

Limited 

ILSI-India 

Abbott Healthcare Pvt. Ltd. 


Akzo Nobel Chemicals BV Research 

& Technology Chemicals 

BASF India Ltd. 

Bayer Bioscience Pvt. Ltd. 

Bikanerwala Foods Pvt. Ltd. 

Britannia Industries Ltd. 

Cargill India Pvt. Ltd. 

Coca-Cola India 

DSM Nutritional Product India Pvt. Ltd. 

General Mills India Pvt. Ltd. 

Herbalife International India Pvt. Ltd. 

Hexagon Nutrition Pvt. Ltd. 

Hindustan Unilever Ltd. 

ITC Foods (a division of ITC Ltd., Inc.) 

Kejriwal Enterprises 

Kellogg India Private Ltd. 

Lonza India Pvt. Ltd. 

Mars Incorporated 

Monsanto Holdings Pvt. Ltd. 

Monsanto Holdings Pvt. Ltd. 

National Dairy Development Board 

Nestlé India Ltd. 

Nicholas Piramal India Ltd. 

PepsiCo India Holdings (P) Ltd. 

(Frito Lay Division) 

Roha Dyechem Pvt. Ltd. 

Sayaji Sethness Ltd. 

Wockhardt Ltd. 

17

2011 ILSI Members 

continued 

ILSI Japan 

ADEKA Corporation 


Ajinomoto General Foods, Inc. 

Amano Enzyme Inc. 

Aohata Corporation 

API Co., Ltd. 

Asahi Group Holdings, Ltd. 

BASF Japan Ltd. 

Bayer Crop Science K.K. 

Calpis Co., Ltd. 

Coca-Cola (Japan) Co., Ltd. 

Coca-Cola Tokyo Research and 

Development Co., Ltd. 

Danisco Japan Ltd. 

Dow Chemical Japan Ltd. 

DuPont Kabushiki Kaisha 

Ensuiko Sugar Refining Co., Ltd. 

Fuji Oil Co., Ltd. 

FUJIFILM Corporation 

International Flavors & Fragrances 

(Japan) Ltd. 

Itoen, Ltd. 

Kagome Co., Ltd. 

Kaneka Corporation 

Kao Corporation 

Kikkoman Corporation 

Kirin Holdings Co., Ltd. 

Knorr Foods Co., Ltd. 

Kyowa Hakko Bio Co., Ltd. 

Lotte Co., Ltd. 

Matsutani Chemical Industry Co., Ltd. 

Megmilk Snow Brand Co., Ltd. 

Meiji Corporation Ltd. 

Mitsubishi Shoji Foodtech Co., Ltd. 

Mitsui Norin Co., Ltd. 

Mitsui Sugar Co., Ltd. 

Miyoshi Oil & Fat Co., Ltd. 

Monsanto Japan Ltd. 

Morinaga & Co., Ltd. 

Morinaga Milk Industry Co., Ltd. 

Nestlé Japan Ltd. 

Nichirei Foods Inc. 

Nihon Firmenich K.K. 

Nihon Kraft Foods Ltd. 

Nippi Inc. 

Nippon Flour Mills Co., Ltd. 

Nippon Meat Packers, Inc. 

Nippon Suisan Kaisha Ltd. 

Nisshin Seifun Group Inc. 

NOF Corporation 

Ogawa & Co., Ltd. 

Otsuka Pharmaceutical Co., Ltd. 

Prima Meat Packers, Ltd. 

Procter & Gamble Japan K.K. 

Riken Vitamin Company, Ltd. 

San-Ei Gen F.F.I., Inc. 

Sapporo Breweries Ltd. 

Shiono Koryo Kaisha, Ltd. 

Showa Sangyo Company, Ltd. 

Soda Aromatic Co, Ltd. 

Suntory Holdings Limited 

Syngenta Japan K.K. 

T. Hasegawa Co., Ltd. 

Taisho Pharmaceutical Co., Ltd. 

Taiyo Kagaku Co., Ltd. 

Takasago International Corporation 

The Nisshin OilliO Group, Ltd. 

Tsukishima Foods Industry Co., Ltd. 

Unilever Japan Service K.K. 

Yakult Honsha Co., Ltd. 

Yamazaki Baking Company, Ltd. 

ILSI Korea 

Ajinomoto Korea, Inc. 

Amway Korea, Ltd. 

BASF Co., Ltd. 

Bayer CropScience 

BIOFOOD Network Center 

CJ CheilJedang Corporation 

Coca-Cola Korea Company, Ltd. 

Corn Products Korea Co., Ltd. 

Daesang Co., Ltd. 

Danisco Cultor 

Dow AgroSciences International Ltd. 

DuPont Korea, Inc. 

HAITAI Confectionery & Foods 

Ilshin Wells Co., Ltd 

JMC Corporation 

Korea Yakult Co., Ltd. 

LOTTE R&D Center 

MARS Korea 

McDonald’s Korea 

Monsanto Korea Inc. 

Nongshim Co., Ltd. 

Pulmuone Co., Ltd 

Samsung Everland Inc. 

Samyang Corporation 

SPC Food Safety Center 

Syngenta Korea Inc. 

ILSI México 

Abbott Laboratories de México, 

S.A. de C.V. 

Colloides Naturels de México, 

S. A. de C. V. 

Corporativo Bimbo, S.A. de C.V. 

DSM Nutritional Products México, 

S.A. de C.V 

Effem México, Inc. y Compañías S. 

en N.C. de C. V. 

Grupo Danone de México, S. A. de C. V. 

Kellogg de México, S. de R. L. de C. V. 

Kraft Foods de México, S. de R. L. 

de C. V. 

Mead & Johnson Nutricionales de 

México, S. de R. L. de C. V. 

Monsanto Comercial, S. A. de C. V. 

Nestlé México, S.A. de C.V. 

Sabritas S. de R. L. de C. V. 

(Frito-Lay; PepsiCo) 

Sensient Colors, S. A. de C. V. 

SIAAG, S.A. de C.V. (Coca-Cola) 

Silliker México, S. A. de C. V. 

Unilever de México, S.A. de C.V. 

Yakult, S.A. de C.V. 

Bayer de México, S.A. De C.V. 

FIRMENICH de México, S. A de C. V. 

Tate & Lyle México, S de R L. de C.V. 

ILSI North America 


Ajinomoto USA Inc 

Archer Daniels Midland Company 

BENEO Group - Palatinit Suedzucker 

Bunge Limited 

Cadbury Adams USA, LLC 

Campbell Soup Company 

Cargill, Incorporated 

18

The Coca-Cola Company 

Cognis Nutrition and Health 

ConAgra Foods, Inc. 

Danisco USA, Inc. 

The Dannon Company, Inc. 

Dr Pepper Snapple Group 

DSM Nutritional Products AG 

General Mills 

The Hershey Company 

H.J. Heinz Company 

Kellogg Company 

Kraft Foods, Inc. 

Mars, Incorporated 

Martek Biosciences Corporation 

McNeil Nutritionals, LLC 

Mead Johnson Company, LLC 


National Starch/Corn Products 

International 

Nestlé USA, Inc. 

Ocean Spray Cranberries, Inc. 

PepsiCo, Inc. 

Procter & Gamble Company 

Red Bull GmbH 

Sara Lee Corporation 

Senomyx, Inc. 

Solae Company, Inc. 

Tate & Lyle 

Unilever 

ILSI North Africa & Gulf Region 

Akzo Nobel Company 

Atlantic Industry (Coca-Cola Egypt) 

Chamber of Food Industries (CFI) 

Holding Company for Food Industries 

Kraft Foods Company 

Pepsi-Cola International 

Safola Egypt 

ILSI North Andean 

Abbott Laboratories de Colombia S.A. 

Agrícola Ganadera Reysahiwal S.A. 

Alfonzo Rivas y Cía 

Alimentos Polar Colombia S.A.S. 

Alpina Productos Alimenticios S.A. 

Cargill de Venezuela CA 

Cervecería Polar 

Clariant (Colombia) S.A./Beneo 

Orafti Latinoamérica 

Coca-Cola de Venezuela 

Coca-Cola Servicios de Colombia, S.A. 

Compañía Agrícola Colombiana 

Compañía de Galletas Noel S.A. 

Congelagro S.A. 

Corn Products Andina Colombia 

Danisco Colombia Ltda. 

DSM Nutritional Products Colombia S.A. 

Ecarni S.A. 

Empresas Polar Venezuela 

Industrial Danec S.A. 

Kellogg de Colombia 

Kraft Foods Colombia Ltda. 

Kraft Foods Ecuador 

Kraft Foods Venezuela C.A. 

La Fabril S.A. 

Mead Johnson Nutritionals Colombia 

Mead Johnson Nutritionals Ecuador 

Mead Johnson Nutritionals Venezuela 

Meals de Colombia S.A. 

Monsanto - Ecuador 

Monsanto - Venezuela 

Nestlé de Colombia 

Nestlé del Ecuador 

Nestlé Venezuela 

Omnilife de Colombia S.A.S. 

Pepsico Alimentos colombia L.T.D.A. 

Pfizer S.A. 

Postobón S.A. 

Productos Alimenticios Doria S.A.S. 

PRONACA C.A. 

Refreshment Product Services 

Ecuador S.A. (Coca-Cola) 

Seatech International (Van Camp´s) 

Snacks America Latina Venezuela 

Sociedad Agrícola e Industrial 

San Carlos 

Tecnas S.A. 

Unilever Andina Colombia 

ILSI South Africa 

Coca-Cola Southern Africa 

DSM Nutritional Products 

MARS Africa 

Monsanto South Africa (Pty.) Ltd. 

Nampak Ltd. 

Nestlé South Africa 

Pioneer Foods(Pty.) Ltd. 

Unilever South Africa Ltd. 

ILSI South Andean 

Coca-Cola de Chile SA 

Danisco Chile S.A. 

DSM Nutritional Products Chile SA 

Herbalife Interacional de Chile 

Kraft Foods Argentina S.A. 

Monsanto Chile S.A. 

Nestle S.A. 

Tresmontes Lucchetti 

Unilever 

ILSI Southeast Asia 


Ajinomoto Co, Inc, ASEAN Headquarters 

Almond Board of California 

BASF East Asia Regional Headquarters 

Limited 

Bayer CropScience Pty Ltd 

BENEO Asia-Pacific Pte. Ltd 

Campbell Arnotts 

Cerebos Pacific Limited 

Danisco New Zealand Ltd 

Danone Research Centre for 

Specialized Nutrition 

DSM Nutritional Products Asia 

Pacific Pte. Ltd. 

Fonterra Cooperative Group Limited 

Kraft Foods 

MARS Incorporated 

Mead Johnson Nutrition (Thailand) Ltd 

Monsanto Singapore Co (Pte) Ltd 

Nestlé R&D Center (Pte.) Ltd. 

Nutrition Strategies International LLC 

Pfizer Inc 

PT Cargill Indonesia 

PT Coca-Cola Indonesia 

Simplot Australia Pty Ltd 

Unilever - Greater China East Asia- 

Australia New Zealand (GCEA-ANZ) 

Yeo Hiap Seng Ltd. 

19

2011 Revenue & Expenses 

Funding comes from membership 

revenues, government grants, corporate 

contributions, and sale of publications. 

Revenues and expenses shown are based 

on unaudited 2011 year-end projections. 

ILSI combines public and private 

resources to achieve more with less. 

Revenue Sources 

Member Support: 70% 

Grants & Contributions: 21% 

Publications: 3% 

Interest & Dividend Income: 3% 

Conference Registration: 2% 

Other Income: 1% 

Expenses 

General & Administrative: 21% 

Conferences & Workshops: 26% 

Publications: 7% 

Research: 7% 

Governance: 5% 

Development: 1% 

Other Program Expenses: 33% 

For information about ILSI, contact: 

International Life Sciences Institute 

1156 Fifteenth Street, NW 

Suite 200 

Washington, DC 20005 

USA 

www.ilsi.org 

International Life Sciences Institute ® , 

ILSI ® , Nutrition Reviews ® , and the 

ILSI logo image of concentric circles 

are trademarks of ILSI. 

©2011 International Life 


All Rights Reserved 

All photographs ©Dreamstime ® 

20

Contact Information 

ILSI 

www.ilsi.org 

Suzanne Harris, PhD 

Executive Director 

ILSI Research Foundation 

www.ilsi.org/ReseachFoundation 

Suzanne Harris, PhD 


Global Branch 



www.hesiglobal.org 

Syril Pettit 


Regional and National Branches 

ILSI Argentina 

www.ilsi.org/Argentina 

Patricia Torres 

Branch Coordinator 

ILSI Brasil 

www.ilsi.org/Brasil 

Mariela Weingarten Beresovsky 


ILSI Europe 

Celebrating 25 years in 2011! 

www.ilsi.org/Europe 

Nico van Belzen, PhD 


ILSI Focal Point in China 

www.ilsi.org/China 

Junshi Chen, PhD 


ILSI-India 

www.ilsi.org/India 

Rekha Sinha 


ILSI Japan 


www.ilsi.org/Japan 

Ryuji Yamaguchi, PhD. 


ILSI Korea 

www.ilsi.org/Korea 

Myeong-Ae Yu, PhD 


ILSI México 


www.ilsi.org/Mexico 

Cecilia Robles 


ILSI North Africa & Gulf Region 

www.ilsi.org/NorthAfrica 

Hanan Zaki 


ILSI North America 

www.ilsina.org 

Eric Hentges, PhD 


ILSI North Andean 

www.ilsi.org/NorthAndean 

Marta Elena Soto Rojas 


ILSI South Africa 

www.ilsi.org/SouthAfrica 

Nick Starke 


ILSI South Andean 

www.ilsi.org/SouthAndean 

Cristina Cisternas 


ILSI Southeast Asia Region 

www.ilsi.org/SEA_Region 

Yeong Boon-Yee 


The International Life Sciences 

Institute (ILSI) is a nonprofit, 

worldwide organization established 

in 1978 to advance scientific 

understanding of nutrition, food 

safety, toxicology, risk assessment, 

and the environment. 

ILSI brings together scientists from 

academia, government, industry, and 

the public sector who work together to 

solve problems of common interest for 

the health and well-being of the public.

International Life 


1156 15th Street, NW 

Suite 200 

Washington, DC 

20005 

1.202.659.0074 telephone 

1.202.659.3859 facsimile 

www.ilsi.org

2011 ILSI Annual Report - International Life Sciences Institute

Create successful ePaper yourself

Delete template?

Save as template?